GLOBAL PRECLINICAL IMAGING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Preclinical imaging is a critical aspect of the research and development (R&D) pipeline in the biomedical sciences, thereby enabling researchers to visualize and track the progression of diseases, assess the pharmacokinetics of drugs, and monitor therapeutic responses in animal models before they are being translated into human clinical trials. This field leverages various imaging modalities, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single-photon emission computed tomography (SPECT), ultrasound (US), and optical imaging (bioluminescence and fluorescence), to gather valuable data about biological processes and the effects of treatments without the need to sacrifice the animal subjects at multiple time points. The advantage of preclinical imaging is that it facilitates the longitudinal studies of disease within the same animal, thus reducing the number of animals required for research and improving the statistical significance of the data collected.  Further on, it allows for the dynamic observation of disease progression and regression in real-time, which can provide insights into the mechanisms of action of therapeutic interventions. The preclinical imaging sector is experiencing significant growth driven by the rising demand for non-invasive imaging techniques and the growth in biomedical research where these modalities are crucial. Advancements in molecular imaging technologies, along with the integration of artificial intelligence (AI) and machine learning (ML) algorithms, are improving image acquisition, processing, and analysis, thus offering deeper insights into disease pathologies and treatment effects. Collaborations between academic institutions, research laboratories, and pharmaceutical companies are also intensifying, thereby providing numerous opportunities for the integration of novel imaging solutions into various research projects. Key market players in the preclinical imaging market are focusing on technological advancements, with an emphasis on hybrid imaging systems that combine two or more imaging modalities. This approach leverages the strengths of each technique to provide a more comprehensive understanding of biological phenomena. Furthermore, emerging markets are also exhibiting robust growth opportunities due to an increase in research activities and the establishment of new research facilities that require preclinical imaging equipment and services.

Market Dynamics:

Rising government investments to promote preclinical research for drug development and disease modeling is a major driver for the preclinical imaging market. However, high costs that are associated with imaging systems pose a challenge. Opportunities lie in the development of affordable and portable imaging devices to support research in academic institutions and emerging markets.

Key features of the study:

• This report provides in-depth analysis of the global preclinical imaging market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global preclinical imaging market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bruker Corporation, Siemens A.G., General Electric (GE), TriFoil Imaging, PerkinElmer, Inc., VisualSonics Inc.(Fujifilm), Inc., Mediso Ltd., Agilent Technologies, MILabs B.V., MR Solutions, and Molecubes.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global preclinical imaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical imaging market

Detailed Segmentation:

• Global Preclinical Imaging Market, By Product
  • CT Imaging
  • MRI Imaging
  • PET/SPECT Imaging
  • Multi-modal Imaging
  • Optical Imaging
  • Ultrasound Imaging
  • Photoacoustic Imaging
  • Reagents
  • Services
• Global Preclinical Imaging Market, By Application
  • Research and Development
  • Drug Discovery          
• Global Preclinical Imaging Market, By End User
  • Pharma and Biotech Companies
  • Research Institutes
  • Others
• Global Preclinical Imaging Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Top Companies in Global Preclinical Imaging Market:
  • Bruker Corporation 
  • Siemens A.G.
  • General Electric(GE)
  • TriFoil Imaging
  • PerkinElmer, Inc.
  • VisualSonics Inc. (Fujifilm), Inc.
  • Mediso Ltd.
  • Agilent Technologies
  • MILabs B.V.
  • MR Solutions
  • Molecubes